Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
DRUG

Methylphenidate

Methylphenidate is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy.

DRUG

Triazolam

Triazolam is a benzodiazepine similar to Valium. Triazolam affects chemicals in the brain that may become unbalanced and cause sleep problems (insomnia). Triazolam is used to treat insomnia (trouble falling or staying asleep).

OTHER

Project: EVO

Project: EVO Monitor was designed to incorporate a proprietary multi-tasking assessment into a state-of-the-art mobile video game-like platform, which deploys modern videogame graphics, engaging reward loops, and real-time adaptive mechanics to dynamically personalize difficulty in order to assess the user's ability.

DRUG

Placebo

Sugar pill

Trial Locations (1)

78229

Clinical Trials of Texas, San Antonio

All Listed Sponsors
lead

Akili Interactive Labs, Inc.

INDUSTRY

NCT02822937 - Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents | Biotech Hunter | Biotech Hunter